tiprankstipranks
Boston Scientific (BSX)
NYSE:BSX
US Market
BSX
Boston Scientific
RESEARCH TOOLSreports
Want to see BSX full AI Analyst Report?

Boston Scientific (BSX) Stock Forecast & Price Target

4,482 Followers
See the Price Targets and Ratings of:

BSX Analyst Ratings

Strong Buy
23Ratings
Strong Buy
21 Buy
2 Hold
0 Sell
Based on 23 analysts giving stock ratings to
Boston
Scientific
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BSX Stock 12 Month Forecast

Average Price Target

$73.70
▲(14.74% Upside)
Based on 23 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $73.70 with a high forecast of $100.00 and a low forecast of $55.00. The average price target represents a 14.74% change from the last price of $64.23.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"42":"$42","107":"$107","58.25":"$58.3","74.5":"$74.5","90.75":"$90.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$100.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":73.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$73.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$55.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[42,58.25,74.5,90.75,107],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.06,47.440000000000005,51.82,56.2,60.58,64.96000000000001,69.34,73.72,78.1,82.48,86.86,91.24000000000001,95.62,{"y":100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.06,45.41692307692308,47.77384615384616,50.13076923076923,52.48769230769231,54.84461538461539,57.20153846153846,59.55846153846154,61.91538461538462,64.27230769230769,66.62923076923077,68.98615384615385,71.34307692307692,{"y":73.7,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,43.06,43.97846153846154,44.89692307692308,45.815384615384616,46.73384615384616,47.652307692307694,48.57076923076923,49.48923076923077,50.40769230769231,51.326153846153844,52.244615384615386,53.16307692307692,54.081538461538464,{"y":55,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":104.78,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.41,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.66,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.85,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.72,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 61,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.01,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.35,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.87,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.22,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 86,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 98,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.5,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 89,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.98,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 71,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.06,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$100.00Average Price Target$73.70Lowest Price Target$55.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on BSX
Josh Jennings
TD Cowen
TD Cowen
$61
Buy
-5.03%
Downside
Reiterated
06/29/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX) and Boston Scientific (NYSE: BSX)
Stifel Nicolaus Analyst forecast on BSX
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$75→$65
Buy
1.20%
Upside
Reiterated
06/25/26
Boston Scientific price target lowered to $65 from $75 at StifelBoston Scientific price target lowered to $65 from $75 at Stifel
BTIG Analyst forecast on BSX
Marie Thibault
BTIG
BTIG
$65
Buy
1.20%
Upside
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: RegenXBio (NASDAQ: RGNX), Cronos Group (NASDAQ: CRON) and Boston Scientific (NYSE: BSX)
Jefferies Analyst forecast on BSX
Matthew Taylor
Jefferies
Jefferies
$100→$67
Buy
4.31%
Upside
Assigned
06/24/26
Boston Scientific price target lowered to $67 from $100 at JefferiesBoston Scientific price target lowered to $67 from $100 at Jefferies
Bank of America Securities Analyst forecast on BSX
Travis Steed
Bank of America Securities
Bank of America Securities
$68→$61
Buy
-5.03%
Downside
Reiterated
06/12/26
Truist’s Travis Steed Reiterates Buy on Boston Scientific, Citing Underappreciated Watchman Upside and Maintaining $68 Price Target
Piper Sandler Analyst forecast on BSX
Matthew O'Brien
Piper Sandler
Piper Sandler
$90→$65
Buy
1.20%
Upside
Reiterated
06/12/26
Boston Scientific price target lowered to $65 from $90 at Piper SandlerBoston Scientific price target lowered to $65 from $90 at Piper Sandler
Truist Financial Analyst forecast on BSX
Richard Newitter
Truist Financial
Truist Financial
$85→$64
Buy
-0.36%
Downside
Assigned
06/04/26
Boston Scientific (BSX) Receives a Buy from Truist Financial
Canaccord Genuity Analyst forecast on BSX
William Plovanic
Canaccord Genuity
Canaccord Genuity
$71→$70
Buy
8.98%
Upside
Reiterated
06/01/26
Boston Scientific price target lowered to $70 from $71 at CanaccordBoston Scientific price target lowered to $70 from $71 at Canaccord
Wolfe Research Analyst forecast on BSX
Michael Polark
Wolfe Research
Wolfe Research
―
Hold
―
Downgraded
05/29/26
Boston Scientific downgraded to Peer Perform from Outperform at Wolfe ResearchBoston Scientific downgraded to Peer Perform from Outperform at Wolfe Research
Citi Analyst forecast on BSX
Joanne Wuensch
Citi
Citi
$87→$70
Buy
8.98%
Upside
Reiterated
05/29/26
Boston Scientific price target lowered to $70 from $87 at CitiBoston Scientific price target lowered to $70 from $87 at Citi
Leerink Partners Analyst forecast on BSX
Mike Kratky
Leerink Partners
Leerink Partners
$87→$74
Buy
15.21%
Upside
Reiterated
05/28/26
Boston Scientific price target lowered to $74 from $87 at LeerinkBoston Scientific price target lowered to $74 from $87 at Leerink
Robert W. Baird Analyst forecast on BSX
David Rescott
Robert W. Baird
Robert W. Baird
$75→$70
Buy
8.98%
Upside
Reiterated
05/28/26
Boston Scientific price target lowered to $70 from $75 at BairdBoston Scientific price target lowered to $70 from $75 at Baird
Barclays Analyst forecast on BSX
Matt Miksic
Barclays
Barclays
$96→$89
Buy
38.56%
Upside
Reiterated
05/28/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on BSX
Larry Biegelsen
Wells Fargo
Wells Fargo
$75→$55
Hold
-14.37%
Downside
Downgraded
05/28/26
Boston Scientific downgraded to Equal Weight from Overweight at Wells FargoBoston Scientific downgraded to Equal Weight from Overweight at Wells Fargo
J.P. Morgan Analyst forecast on BSX
Robbie Marcus
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
05/27/26
Robbie Marcus Maintains Buy Rating on Boston Scientific Despite Near-Term WATCHMAN Headwinds, Citing Intact Long-Term Growth Outlook
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on BSX
Josh Jennings
TD Cowen
TD Cowen
$61
Buy
-5.03%
Downside
Reiterated
06/29/26
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX) and Boston Scientific (NYSE: BSX)
Stifel Nicolaus Analyst forecast on BSX
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$75→$65
Buy
1.20%
Upside
Reiterated
06/25/26
Boston Scientific price target lowered to $65 from $75 at StifelBoston Scientific price target lowered to $65 from $75 at Stifel
BTIG Analyst forecast on BSX
Marie Thibault
BTIG
BTIG
$65
Buy
1.20%
Upside
Reiterated
06/25/26
Analysts Offer Insights on Healthcare Companies: RegenXBio (NASDAQ: RGNX), Cronos Group (NASDAQ: CRON) and Boston Scientific (NYSE: BSX)
Jefferies Analyst forecast on BSX
Matthew Taylor
Jefferies
Jefferies
$100→$67
Buy
4.31%
Upside
Assigned
06/24/26
Boston Scientific price target lowered to $67 from $100 at JefferiesBoston Scientific price target lowered to $67 from $100 at Jefferies
Bank of America Securities Analyst forecast on BSX
Travis Steed
Bank of America Securities
Bank of America Securities
$68→$61
Buy
-5.03%
Downside
Reiterated
06/12/26
Truist’s Travis Steed Reiterates Buy on Boston Scientific, Citing Underappreciated Watchman Upside and Maintaining $68 Price Target
Piper Sandler Analyst forecast on BSX
Matthew O'Brien
Piper Sandler
Piper Sandler
$90→$65
Buy
1.20%
Upside
Reiterated
06/12/26
Boston Scientific price target lowered to $65 from $90 at Piper SandlerBoston Scientific price target lowered to $65 from $90 at Piper Sandler
Truist Financial Analyst forecast on BSX
Richard Newitter
Truist Financial
Truist Financial
$85→$64
Buy
-0.36%
Downside
Assigned
06/04/26
Boston Scientific (BSX) Receives a Buy from Truist Financial
Canaccord Genuity Analyst forecast on BSX
William Plovanic
Canaccord Genuity
Canaccord Genuity
$71→$70
Buy
8.98%
Upside
Reiterated
06/01/26
Boston Scientific price target lowered to $70 from $71 at CanaccordBoston Scientific price target lowered to $70 from $71 at Canaccord
Wolfe Research Analyst forecast on BSX
Michael Polark
Wolfe Research
Wolfe Research
―
Hold
―
Downgraded
05/29/26
Boston Scientific downgraded to Peer Perform from Outperform at Wolfe ResearchBoston Scientific downgraded to Peer Perform from Outperform at Wolfe Research
Citi Analyst forecast on BSX
Joanne Wuensch
Citi
Citi
$87→$70
Buy
8.98%
Upside
Reiterated
05/29/26
Boston Scientific price target lowered to $70 from $87 at CitiBoston Scientific price target lowered to $70 from $87 at Citi
Leerink Partners Analyst forecast on BSX
Mike Kratky
Leerink Partners
Leerink Partners
$87→$74
Buy
15.21%
Upside
Reiterated
05/28/26
Boston Scientific price target lowered to $74 from $87 at LeerinkBoston Scientific price target lowered to $74 from $87 at Leerink
Robert W. Baird Analyst forecast on BSX
David Rescott
Robert W. Baird
Robert W. Baird
$75→$70
Buy
8.98%
Upside
Reiterated
05/28/26
Boston Scientific price target lowered to $70 from $75 at BairdBoston Scientific price target lowered to $70 from $75 at Baird
Barclays Analyst forecast on BSX
Matt Miksic
Barclays
Barclays
$96→$89
Buy
38.56%
Upside
Reiterated
05/28/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on BSX
Larry Biegelsen
Wells Fargo
Wells Fargo
$75→$55
Hold
-14.37%
Downside
Downgraded
05/28/26
Boston Scientific downgraded to Equal Weight from Overweight at Wells FargoBoston Scientific downgraded to Equal Weight from Overweight at Wells Fargo
J.P. Morgan Analyst forecast on BSX
Robbie Marcus
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
05/27/26
Robbie Marcus Maintains Buy Rating on Boston Scientific Despite Near-Term WATCHMAN Headwinds, Citing Intact Long-Term Growth Outlook
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Boston Scientific

3 Months
Marie ThibaultBTIG
Success Rate
27/40 ratings generated profit
68%
Average Return
+1.67%
Copying Marie Thibault's trades and holding each position for 3 Months would result in 67.50% of your transactions generating a profit, with an average return of +1.67% per trade.
1 Year
Jayson BedfordRaymond James
Success Rate
40/54 ratings generated profit
74%
Average Return
+12.07%
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 74.07% of your transactions generating a profit, with an average return of +12.07% per trade.
2 Years
Jayson BedfordRaymond James
Success Rate
42/54 ratings generated profit
78%
Average Return
+22.90%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +22.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BSX Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
17
30
36
25
11
Buy
69
68
53
46
25
Hold
0
1
3
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
86
99
92
74
38
In the current month, BSX has received 36 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the past 3 months is 73.70.
Each month's total comprises the sum of three months' worth of ratings.

BSX Financial Forecast

BSX Earnings Forecast

Next quarter’s earnings estimate for BSX is $0.83 with a range of $0.81 to $0.84. The previous quarter’s EPS was $0.80. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.
Next quarter’s earnings estimate for BSX is $0.83 with a range of $0.81 to $0.84. The previous quarter’s EPS was $0.80. BSX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Sales Forecast

Next quarter’s sales forecast for BSX is $5.37B with a range of $5.32B to $5.42B. The previous quarter’s sales results were $5.20B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.
Next quarter’s sales forecast for BSX is $5.37B with a range of $5.32B to $5.42B. The previous quarter’s sales results were $5.20B. BSX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year BSX has Performed in-line its overall industry.

BSX Stock Forecast FAQ

What is BSX’s average 12-month price target, according to analysts?
Based on analyst ratings, Boston Scientific’s 12-month average price target is 73.70.
    What is BSX’s upside potential, based on the analysts’ average price target?
    Boston Scientific has 14.74% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BSX a Buy, Sell or Hold?
          Boston Scientific has a consensus rating of Strong Buy which is based on 21 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Boston Scientific’s price target?
            The average price target for Boston Scientific is 73.70. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $100.00 ,the lowest forecast is $55.00. The average price target represents 14.74% Increase from the current price of $64.23.
              What do analysts say about Boston Scientific?
              Boston Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.
                How can I buy shares of BSX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.